Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zelira Therapeutics Ltd. (ZLDAF)
:ZLDAF
ZLDAF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.16 - $0.66
Previous CloseN/A
Volume342.00
Average Volume (3M)11.00
Market Cap
$3.53M
Enterprise Value$6.77M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.11
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.10
Shares Outstanding11,347,155
10 Day Avg. Volume1
30 Day Avg. Volume11
Standard Deviation0.35
R-Squared0.07
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)454.20
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Zelira Therapeutics News
PremiumCompany Announcements
Zelira Therapeutics Advances HOPE® Program with Secured FDA Trial Funding
PremiumCompany Announcements
Zelira Therapeutics Secures Fourth Funding Tranche to Advance FDA Trials
PremiumCompany Announcements
Zelira Therapeutics Announces Change in Director’s Interest
PremiumCompany Announcements
Zelira Therapeutics Issues Convertible Notes
PremiumCompany Announcements
Zelira Therapeutics Issues 3.5 Million Convertible Notes
PremiumCompany Announcements
Zelira Therapeutics Unveils Growth Plans at Investment Conference
PremiumCompany Announcements
Zelira Therapeutics Secures Shareholder Support at AGM---
ZLDAF FAQ
What was Zelira Therapeutics Ltd.’s price range in the past 12 months?
Zelira Therapeutics Ltd. lowest stock price was $0.16 and its highest was $0.66 in the past 12 months.
What is Zelira Therapeutics Ltd.’s market cap?
Zelira Therapeutics Ltd.’s market cap is $3.53M.
When is Zelira Therapeutics Ltd.’s upcoming earnings report date?
Zelira Therapeutics Ltd.’s upcoming earnings report date is Aug 27, 2025 which is in 185 days.
How were Zelira Therapeutics Ltd.’s earnings last quarter?
Currently, no data Available
Is Zelira Therapeutics Ltd. overvalued?
According to Wall Street analysts Zelira Therapeutics Ltd.’s price is currently Overvalued.
Does Zelira Therapeutics Ltd. pay dividends?
Zelira Therapeutics Ltd. does not currently pay dividends.
What is Zelira Therapeutics Ltd.’s EPS estimate?
Zelira Therapeutics Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zelira Therapeutics Ltd. have?
Zelira Therapeutics Ltd. has 11,347,155 shares outstanding.
What happened to Zelira Therapeutics Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Zelira Therapeutics Ltd.?
Currently, no hedge funds are holding shares in ZLDAF
---
Zelira Therapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
ZLDAF Sentiment 70%
Sector Average 70%
Sector Average 70%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-46.85%
12-Months-Change
Fundamentals
Return on Equity
-263.02%
Trailing 12-Months
Asset Growth
-84.65%
Trailing 12-Months
Company Description
Zelira Therapeutics Ltd.
Zelira Therapeutics Ltd, formerly Zelda Therapeutics Ltd is an Australia-based biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in a breast, brain, and pancreatic cancer.
---
Technical Analysis
---